• search hit 12 of 84
Back to Result List

Patients may benefit from re-challenge therapy with the novel radiohybrid PSMA-ligand [177Lu]Lu-rhPSMA-10.1 after progression with [177Lu]Lu-PSMA-I&T [Abstract]

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Alexander Gäble, Andreas Rinscheid, Marianne PattGND, Alexander Dierks, Malte Kircher, Christian Pfob, Hermann Wengenmair, Georgine Wienand, Tilman Janzen, Constantin LapaORCiDGND, Ralph Bundschuh
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/118165
URL:https://jnm.snmjournals.org/content/65/supplement_2/241731
ISSN:0161-5505OPAC
ISSN:1535-5667OPAC
Parent Title (English):Journal of Nuclear Medicine
Publisher:Society of Nuclear Medicine and Molecular Imaging
Place of publication:Reston, VA
Type:Article
Language:English
Date of Publication (online):2025/01/20
Year of first Publication:2024
Publishing Institution:Universität Augsburg
Release Date:2025/01/20
Volume:65
Issue:Supplement 2
First Page:241731
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Lehrstuhl für Nuklearmedizin